Drug Profile
Artesunate - La Jolla Pharmaceutical Company
Alternative Names: Artesunate; LJPC-0118Latest Information Update: 18 Oct 2022
Price :
$50
*
At a glance
- Originator La Jolla Pharmaceutical Company
- Class 3-ring heterocyclic compounds; Antimalarials; Artemisinins; Small molecules; Succinates
- Mechanism of Action Free radical stimulants; Sarcoplasmic reticulum calcium-transporting ATPase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Registered Malaria